Compare Stocks → SHOCKING Crypto Leak… (From Crypto 101 Media) (Ad) Compare stocks and their fundamentals, performance, price, and technicals. Use this free stock comparison tool to evaluate companies based on their analyst ratings, book value, debt, dividend, MarketRank, news sentiment, price performance, profitability, and more. Enter up to ten stock symbols separated by a comma or space (ex. BAC, JPM, WFC, C, GS). Comparison Ideas Agriculture StocksAirline StocksApparel StocksArtificial Intelligence StocksAutomotive StocksBank StocksBitcoin StocksBlockchain StocksCanadian StocksCannabis StocksCasino StocksChatGPT StocksChinese StocksCloud Storage StocksCoronavirus Therapeutics StocksCryptocurrency StocksCybersecurity StocksDefense StocksDividend StocksDow 30 StocksEcommerce StocksElectric Vehicles StocksEnergy StocksEntertainment StockseSports StocksEV Charging StocksFertilizer StocksGold StocksGrocery StocksGrowth StocksHealthcare StocksHigh Dividend StocksHome Office StocksHotel StocksLarge Cap StocksLeisure StocksLithium StocksMagnificent Seven StocksMATANA StocksMega Cap StocksMeme StocksMetaverse StocksMid Cap StocksMining StocksMusic Industry StocksNanotechnology StocksNFT StocksOil StocksOutdoor Activities StocksPharmaceutical StocksRenewable Energy StocksRestaurant StocksRetail StocksSemiconductor StocksSocial Media StocksSolar StocksSpace StocksStay-At-Home StocksTechnology StocksTelecom StocksToy StocksUtility StocksVaccine StocksVideo Game StocksVirtual Reality StocksWallStreetBets Stocks Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare Share Comparison Share Comparison CNSX:VP Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Stocks - Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeVPVodis Pharmaceuticals$0.00$0.16▼$0.62N/AN/A1,714 shs51,582 shsTen Starter Stocks For Beginners to Buy NowJust getting into the stock market? These 10 simple stocks can help beginning investors build long-term wealth without knowing options, technicals, or other advanced strategies.Get This Free ReportPrice PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceVPVodis Pharmaceuticals0.00%0.00%0.00%0.00%0.00%Tiny Biotech Stock Wins $75 Billion Patent (Ad)A little-known biotech has been quietly working on revolutionary treatments for neurodegenerative diseases. Most people have never heard of them... but those in the know have been taking notice. Jeff Bezos cut them a check for $130 million. Fidelity Biosciences for a further $217 million. They've even had several collaborative partnerships with much larger companies like Biogen, Sanofi, and Takeda.Find out more here >>>MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationVPVodis PharmaceuticalsN/AN/AN/AN/AN/AN/AN/AN/AAnalyst RatingsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceVPVodis PharmaceuticalsN/AN/AN/AN/ASales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookVPVodis PharmaceuticalsN/AN/AN/AN/AN/AN/AProfitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateVPVodis PharmaceuticalsN/AN/A0.00N/AN/AN/AN/AN/AN/ADividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthVPVodis PharmaceuticalsN/AN/AN/AN/AN/AOwnershipInstitutional OwnershipCompanyInstitutional OwnershipVPVodis PharmaceuticalsN/AInsider OwnershipCompanyInsider OwnershipVPVodis PharmaceuticalsN/AMiscellaneousCompanyEmployeesShares OutstandingFree FloatOptionableVPVodis PharmaceuticalsN/AN/AN/ANot OptionableVP, REDD, IPEL, and MANX HeadlinesSourceHeadlineCOVETRUS® TRANSFORMS PRESCRIPTION MANAGEMENT FOR VETERINARY PRACTICES WITH INTRODUCTION OF vRxPro™tmcnet.com - March 27 at 1:27 PMStates' drug pricing boards off to a slow startmsn.com - March 22 at 8:16 AMGLP-1s set to take drug sales throne from PD-1 inhibitors in 2024mmm-online.com - March 20 at 6:45 PMVerrica Pharmaceuticals Set to Discuss Q4 and Full-Year 2023 Financial Results in Upcoming Conference Callmsn.com - February 25 at 2:28 PMAbivax appoints Ana Sharma as Vice President, Global Head of Qualitymarkets.businessinsider.com - February 7 at 8:56 AMMedicines360 Appoints Lisa David as Chair of the Board of Directors, Strengthening its Commitment to Women’s Healthmarkets.businessinsider.com - January 24 at 1:10 PMSenior Vice Presidentgovtech.com - December 20 at 9:06 AMDr Reddy's becomes sole Indian pharma player to make it to Dow Jones Sustainability World Index 2023msn.com - December 14 at 3:30 PMBiden warns Big Pharma: Make your drugs cheaper or the US government will override your patentsmsn.com - December 7 at 3:45 PMThe White House is threatening the patents of high-priced drugs developed with taxpayer dollarsabcnews.go.com - December 7 at 9:38 AMAmneal Pharma in pact with Strides to launch generic Vascepamsn.com - December 1 at 3:25 PMAnavex Life Sciences Appoints Senior VP of Regulatory Affairsmarkets.businessinsider.com - November 6 at 8:21 AMXpeng's vice president suspended amid corruption investigation in supply chain managementfoxnews.com - October 14 at 11:38 PMLexicon Pharmaceuticals Up 20% on Express Scripts Designation for Inpefa Heart Drugmarketwatch.com - October 9 at 6:33 PMStrengthening of vertical integration: Exyte completes acquisition of pure media specialist Integamarkets.businessinsider.com - October 4 at 6:44 AMVice Presidentnewsweek.com - September 19 at 1:02 PMRepublican voters want Donald Trump. And his vice president? How about more Trump?usatoday.com - August 28 at 4:23 AMTeva Pharmaceuticals to pay $225M fine to settle price-fixing chargesnews.yahoo.com - August 22 at 4:12 AMVertex Pharmaceuticals (VRTX) Q2 2023 Earnings Call Transcriptmsn.com - August 1 at 10:03 PMSee which pharma brands are the strongest and fastest-growing in 2023mmm-online.com - July 12 at 1:54 PMSenior Vice President, Corporate Development and Global Strategywebmd.com - June 9 at 11:51 PMWhat has Kamala Harris done as vice president?news.yahoo.com - May 29 at 8:36 AMAHIP Marketing Campaign Targets Pharma’s Prescription Drug Pricinghealthpayerintelligence.com - April 24 at 7:41 PMMeet our President and Vice Chancellorlse.ac.uk - April 9 at 10:43 PMMedia Sentiment Over TimeTop Headlines3 Value Stocks Too Small For Buffett’s PortfolioMarch 28, 2024 12:16 PMView 3 Value Stocks Too Small For Buffett’s PortfolioFoot Locker Builds Up Another Head of Steam; Gains ImminentMarch 28, 2024 10:58 AMView Foot Locker Builds Up Another Head of Steam; Gains Imminent5 Stocks in the Current Bull Market with Upside to ComeApril 5, 2024 10:14 AMView 5 Stocks in the Current Bull Market with Upside to ComeLow Interest Rates Can Help These Commercial Banks Rally HigherApril 2, 2024 11:38 AMView Low Interest Rates Can Help These Commercial Banks Rally HigherDoes Reddit's Successful Public Debut Mean Tech IPOs are Back?March 22, 2024 6:15 AMView Does Reddit's Successful Public Debut Mean Tech IPOs are Back?All Headlines Company DescriptionsVodis PharmaceuticalsCNSX:VPVodis Pharmaceuticals Inc. operates as an application stage company for producing medical marijuana. It operates in Canada and the United States. The company is based in Delta, Canada. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.